vs

Side-by-side financial comparison of Cellebrite DI Ltd. (CLBT) and ExlService Holdings, Inc. (EXLS). Click either name above to swap in a different company.

ExlService Holdings, Inc. is the larger business by last-quarter revenue ($542.6M vs $292.2M, roughly 1.9× Cellebrite DI Ltd.). ExlService Holdings, Inc. runs the higher net margin — 11.1% vs -103.5%, a 114.6% gap on every dollar of revenue. ExlService Holdings, Inc. produced more free cash flow last quarter ($106.5M vs $60.8M). Over the past eight quarters, Cellebrite DI Ltd.'s revenue compounded faster (72.8% CAGR vs 11.5%).

Cellebrite DI Ltd. is a digital forensics company headquartered in Petah Tikva, Israel that provides tools for law enforcement agencies as well as enterprise companies and service providers to collect, review, analyze and manage digital data. Their flagship product series is the Cellebrite UFED.

Exlservice Holdings, Inc. is a global analytics and digital solutions company serving industries including insurance, healthcare, banking and financial services, media, retail, and others. The company is headquartered in New York and has more than 54,000 professionals in locations throughout the United States, Europe, Asia, Latin America, Australia and South Africa.

CLBT vs EXLS — Head-to-Head

Bigger by revenue
EXLS
EXLS
1.9× larger
EXLS
$542.6M
$292.2M
CLBT
Higher net margin
EXLS
EXLS
114.6% more per $
EXLS
11.1%
-103.5%
CLBT
More free cash flow
EXLS
EXLS
$45.7M more FCF
EXLS
$106.5M
$60.8M
CLBT
Faster 2-yr revenue CAGR
CLBT
CLBT
Annualised
CLBT
72.8%
11.5%
EXLS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CLBT
CLBT
EXLS
EXLS
Revenue
$292.2M
$542.6M
Net Profit
$-302.3M
$60.2M
Gross Margin
84.6%
38.6%
Operating Margin
14.1%
14.4%
Net Margin
-103.5%
11.1%
Revenue YoY
12.7%
Net Profit YoY
18.9%
EPS (diluted)
$-1.50
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLBT
CLBT
EXLS
EXLS
Q4 25
$542.6M
Q3 25
$292.2M
$529.6M
Q2 25
$220.8M
$514.5M
Q1 25
$89.6M
$501.0M
Q4 24
$481.4M
Q3 24
$232.1M
$472.1M
Q2 24
$185.3M
$448.4M
Q1 24
$71.2M
$436.5M
Net Profit
CLBT
CLBT
EXLS
EXLS
Q4 25
$60.2M
Q3 25
$-302.3M
$58.2M
Q2 25
$36.9M
$66.1M
Q1 25
$-71.4M
$66.6M
Q4 24
$50.7M
Q3 24
$53.0M
Q2 24
$-95.2M
$45.8M
Q1 24
$-40.6M
$48.8M
Gross Margin
CLBT
CLBT
EXLS
EXLS
Q4 25
38.6%
Q3 25
84.6%
38.5%
Q2 25
84.1%
37.7%
Q1 25
85.2%
38.6%
Q4 24
38.1%
Q3 24
83.5%
37.8%
Q2 24
84.1%
37.1%
Q1 24
82.6%
37.4%
Operating Margin
CLBT
CLBT
EXLS
EXLS
Q4 25
14.4%
Q3 25
14.1%
14.4%
Q2 25
12.1%
15.8%
Q1 25
10.3%
15.7%
Q4 24
14.8%
Q3 24
7.9%
14.7%
Q2 24
11.7%
13.7%
Q1 24
0.2%
14.1%
Net Margin
CLBT
CLBT
EXLS
EXLS
Q4 25
11.1%
Q3 25
-103.5%
11.0%
Q2 25
16.7%
12.8%
Q1 25
-79.7%
13.3%
Q4 24
10.5%
Q3 24
11.2%
Q2 24
-51.4%
10.2%
Q1 24
-57.0%
11.2%
EPS (diluted)
CLBT
CLBT
EXLS
EXLS
Q4 25
$0.38
Q3 25
$-1.50
$0.36
Q2 25
$0.15
$0.40
Q1 25
$-0.36
$0.40
Q4 24
$0.31
Q3 24
$-0.35
$0.33
Q2 24
$-0.48
$0.28
Q1 24
$-0.21
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLBT
CLBT
EXLS
EXLS
Cash + ST InvestmentsLiquidity on hand
$191.7M
$328.4M
Total DebtLower is stronger
$298.6M
Stockholders' EquityBook value
$336.0M
$912.7M
Total Assets
$690.6M
$1.7B
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLBT
CLBT
EXLS
EXLS
Q4 25
$328.4M
Q3 25
$191.7M
$390.1M
Q2 25
$326.1M
$353.3M
Q1 25
$191.7M
$331.4M
Q4 24
$340.6M
Q3 24
$189.5M
$325.8M
Q2 24
$178.6M
$276.1M
Q1 24
$189.5M
$246.2M
Total Debt
CLBT
CLBT
EXLS
EXLS
Q4 25
$298.6M
Q3 25
$354.8M
Q2 25
$260.0M
Q1 25
$307.3M
Q4 24
$288.5M
Q3 24
$344.7M
Q2 24
Q1 24
Stockholders' Equity
CLBT
CLBT
EXLS
EXLS
Q4 25
$912.7M
Q3 25
$336.0M
$952.4M
Q2 25
$408.4M
$1.1B
Q1 25
$336.0M
$1.0B
Q4 24
$929.9M
Q3 24
$34.2M
$907.6M
Q2 24
$-40.2M
$852.6M
Q1 24
$34.2M
$803.3M
Total Assets
CLBT
CLBT
EXLS
EXLS
Q4 25
$1.7B
Q3 25
$690.6M
$1.7B
Q2 25
$787.4M
$1.7B
Q1 25
$690.6M
$1.7B
Q4 24
$1.6B
Q3 24
$532.9M
$1.6B
Q2 24
$556.6M
$1.5B
Q1 24
$532.9M
$1.4B
Debt / Equity
CLBT
CLBT
EXLS
EXLS
Q4 25
0.33×
Q3 25
0.37×
Q2 25
0.25×
Q1 25
0.30×
Q4 24
0.31×
Q3 24
0.38×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLBT
CLBT
EXLS
EXLS
Operating Cash FlowLast quarter
$66.2M
$117.4M
Free Cash FlowOCF − Capex
$60.8M
$106.5M
FCF MarginFCF / Revenue
20.8%
19.6%
Capex IntensityCapex / Revenue
1.8%
2.0%
Cash ConversionOCF / Net Profit
1.95×
TTM Free Cash FlowTrailing 4 quarters
$172.1M
$298.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLBT
CLBT
EXLS
EXLS
Q4 25
$117.4M
Q3 25
$66.2M
$120.7M
Q2 25
$53.5M
$109.4M
Q1 25
$10.0M
$3.2M
Q4 24
$105.3M
Q3 24
$58.2M
$110.1M
Q2 24
$24.6M
$74.9M
Q1 24
$12.5M
$-21.9M
Free Cash Flow
CLBT
CLBT
EXLS
EXLS
Q4 25
$106.5M
Q3 25
$60.8M
$106.4M
Q2 25
$47.5M
$95.0M
Q1 25
$8.5M
$-9.7M
Q4 24
$95.3M
Q3 24
$55.3M
$97.3M
Q2 24
$21.0M
$62.8M
Q1 24
$11.4M
$-33.1M
FCF Margin
CLBT
CLBT
EXLS
EXLS
Q4 25
19.6%
Q3 25
20.8%
20.1%
Q2 25
21.5%
18.5%
Q1 25
9.5%
-1.9%
Q4 24
19.8%
Q3 24
23.8%
20.6%
Q2 24
11.3%
14.0%
Q1 24
16.0%
-7.6%
Capex Intensity
CLBT
CLBT
EXLS
EXLS
Q4 25
2.0%
Q3 25
1.8%
2.7%
Q2 25
2.7%
2.8%
Q1 25
1.7%
2.6%
Q4 24
2.1%
Q3 24
1.3%
2.7%
Q2 24
1.9%
2.7%
Q1 24
1.5%
2.6%
Cash Conversion
CLBT
CLBT
EXLS
EXLS
Q4 25
1.95×
Q3 25
2.08×
Q2 25
1.45×
1.66×
Q1 25
0.05×
Q4 24
2.08×
Q3 24
2.08×
Q2 24
1.63×
Q1 24
-0.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLBT
CLBT

Subscription services$197.2M67%
Term-license$60.8M21%
Professional services$23.2M8%
Other non-recurring$11.0M4%

EXLS
EXLS

Insurance$185.8M34%
Healthcare And Life Sciences$142.2M26%
Banking Capital Markets And Diversified Industries$122.6M23%
International Growth Markets$92.0M17%

Related Comparisons